Vitamin B12, demyelination, remyelination and repair in multiple sclerosis

  title={Vitamin B12, demyelination, remyelination and repair in multiple sclerosis},
  author={Ariel Miller and Maya Korem and Ronit Almog and Yanina Galboiz},
  journal={Journal of the Neurological Sciences},

Figures from this paper

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure

Results have led to a critical reassessment of MS pathogenesis, partly because EGF has little or no role in immunology, and other non-immunological MS abnormalities are reviewed.

Vitamin B12 Deficiency and Multiple Sclerosis; Is there Any Association?

The findings did not support any association between B12 deficiency and MS and there was no correlation between the concentration of serum vitamin B12 and disease’ age of onset, duration, subtypes, or disability status.

Vitamin B Complex and Experimental Autoimmune Encephalomyelitis –Attenuation of the Clinical Signs and Gut Microbiota Dysbiosis

It is demonstrated that VBC treatment ameliorated the cellular changes in the affected peripheral nerve, muscles innervated by this nerve, and the gut microbiota dysbiosis which occurred during the EAE.

High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study.

Supplemental high-dose vitamins B1, B6 and B12 resulted as effective therapy to improve visual function parameters in MS-related visual persistent disability.

The Role of Neurotropic B Vitamins in Nerve Regeneration

The presence of vitamins B1, B6, and B12 paves the way out to the following important regeneration by supporting the development of new cell structures.



Vitamin B12 metabolism in multiple sclerosis.

Vitamin B12 metabolism in patients with multiple sclerosis had significantly lower serum vitamin B12 levels and significantly higher unsaturated R-binder capacities than neurological and normal controls, and they were significantly macrocytic compared with normal controls.

Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study.

The evoked potential and MRI changes in vitamin B12 deficiency neurological syndrome are consistent with focal demyelination of white matter in spinal cord and optic nerve.

Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone

It is hypothesized that low or reduced vitamin B12/folate levels found in MS patients may be related to previous corticosteroid treatments and further studies may be required to clarify the vitamin B 12 and folate metabolism in patients with MS.

Moderate hyperhomocysteinemia and immune activation.

Moderate hyperhomocysteinemia is associated with an increased risk of atherosclerosis, thrombosis and neurodegenerative diseases, and the question is addressed, whether effects attributed to homocysteine, are not rather the consequence of folate and vitamin B12-deficiency.

Serum cobalamin deficiency is uncommon in multiple sclerosis.

The frequency of biologically severe Cbl deficiency in patients with multiple sclerosis and idiopathic myelopathy was very low, and serum Cbl and folate levels were determined in all patients whose Cbl levels were lower than 301 pg/mL.

New Basis of the Neurotrophic Action of Vitamin B12

The results of these studies strongly support the notion that cobalamin plays a pivotal role in regulating the balance of the network of cytokines and growth factors in the central nervous system of the rat.

Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b.

Since some symptoms of thyroid dysfunction may be difficult to distinguish from typical MS-related symptoms, thyroid hormone levels should be checked when unexplained constitutional symptoms occur during IFN-beta-1b therapy.

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin‐4 production and associated eosinophilia

Both CY/MP‐ and MP‐treated groups had decreased production of IFN‐γ compared with untreated MS, and pronounced immune deviation favoring Th2‐type responses after pulse cyclophosphamide therapy is demonstrated.

Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis

Patients with Whipple's disease can develop mental and psychiatric changes, suprancuclear gaze palsy, upper motoneuron signs, hypothalamic dysfunction, cranial nerve abnormalities, seizures, ataxia, myorhythmia and sensory deficits.